NYU Langone’s Laura and Isaac Perlmutter Cancer Center
In research, NYU Langone’s Laura and Isaac Perlmutter Cancer Center stands highest in Medicine (#13,480 of 17,978 worldwide) and Health Sciences (#16,334 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #11,495 of 28,054 · #18,780 all time
- Rank in ??
- #208 of 692
- Research works
- 215 ▲ 346% vs 2013–17
- Citations
- 5.8k 26.8 per fractional work
- Top-10% rate
- 17.3% record average 16.5%
- Open access
- 50% world 28%
What is NYU Langone’s Laura and Isaac Perlmutter Cancer Center known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #13,480 of 17,978 | 16.5% | 131 | |
| Health SciencesDomain | #16,334 of 20,462 | 16.4% | 135 |
Each strip is that field’s whole ranked pool, with the notch where NYU Langone’s Laura and Isaac Perlmutter Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.2×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.2×
- Medicine 3.2×
- Immunology and Microbiology 3.0×
- Economics, Econometrics and Finance 1.7×
- Health Professions 1.1×
- Neuroscience 0.9×
- Physics and Astronomy 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Nursing 0.3×
- Chemistry 0.2×
- Dentistry 0.2×
- Mathematics 0.2×
- Decision Sciences 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Psychology 0.1×
- Materials Science 0.0×
- Social Sciences 0.0×
Which keywords describe research at NYU Langone’s Laura and Isaac Perlmutter Cancer Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Immunotherapy, Targeted Therapy, Clinical Trials, Prognostic Factors, Clinical Practice Guidelines and Survival Analysis.
- Molecular Characterization
- ALK Inhibitors
- Mutational Signatures
- Global Surveillance
- Cancer Genomics
- PD-1 and PD-L1
- Adjuvant Therapy
- Biomarkers
- International Myeloma Working Group
- Diagnosis Criteria
- Breast Cancer
- Neoadjuvant Therapy
- Metastasis
- Minimal Residual Disease
- Cancer Therapy
- Precision Medicine
- Clinical Practice Guidelines
- Prognostic Factors
- Targeted Therapy
- Radiotherapy
- Chemotherapy
- Immunotherapy
- Clinical Trials
- Cancer
- Survival Analysis
- Tumor Microenvironment
- Cancer Incidence
- Population-Based Study
- Genomic Instability
- Proteasome Inhibitors
- Tumor Staging
- Genomic Profiling
- Molecular Subtypes
- Gene Expression
- Immune Checkpoint Blockade
- Health Disparities
- Cell-Free DNA
- Mortality Rates
- Lymphoma
- EGFR Mutations
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy11▲ 17×18 topics
- Radiotherapy8▲ 22×10 topics
- Immunotherapy7▲ 11×12 topics
- Targeted Therapy7▲ 33×4 topics
- Clinical Trials6▲ 11×10 topics
- Prognostic Factors5▲ 12×11 topics
- Cancer5▲ 3.9×25 topics
- Clinical Practice Guidelines4▲ 8.9×10 topics
- Survival Analysis4▲ 17×6 topics
- Precision Medicine4▲ 9.8×4 topics
- Tumor Microenvironment4▲ 10×7 topics
- Cancer Therapy4▲ 7.7×12 topics
- Cancer Incidence4▲ 31×4 topics
- Minimal Residual Disease4▲ 61×2 topics
- Population-Based Study4▲ 58×2 topics
- Metastasis3▲ 11×8 topics
- Genomic Instability3▲ 33×3 topics
- Neoadjuvant Therapy3▲ 15×5 topics
- Proteasome Inhibitors3▲ 50×2 topics
- Breast Cancer3▲ 15×10 topics
- Tumor Staging3▲ 31×2 topics
- Diagnosis Criteria3▲ 93×1 topic
- Genomic Profiling3▲ 32×2 topics
- International Myeloma Working Group3▲ 93×1 topic
- Molecular Subtypes3▲ 39×2 topics
- Biomarkers3▲ 4.8×7 topics
- Gene Expression3▲ 5.2×7 topics
- Adjuvant Therapy3▲ 25×2 topics
- Immune Checkpoint Blockade3▲ 28×1 topic
- PD-1 and PD-L13▲ 28×1 topic
- Health Disparities3▲ 12×2 topics
- Cancer Genomics3▲ 39×1 topic
- Cell-Free DNA3▲ 30×2 topics
- Global Surveillance3▲ 63×1 topic
- Mortality Rates3▲ 30×1 topic
- Mutational Signatures3▲ 39×1 topic
- Lymphoma2▲ 17×4 topics
- ALK Inhibitors2▲ 42×1 topic
- EGFR Mutations2▲ 42×1 topic
- Molecular Characterization2▲ 15×4 topics
Which research topics does NYU Langone’s Laura and Isaac Perlmutter Cancer Center publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Global Cancer Incidence and Screening.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 3 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 Cancer Genomics and Diagnostics Cancer Research 3 works
- 4 Global Cancer Incidence and Screening Oncology 3 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 8 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 9 Breast Cancer Treatment Studies Cancer Research 2 works
- 10 Advanced Radiotherapy Techniques Radiation 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has NYU Langone’s Laura and Isaac Perlmutter Cancer Center's research output changed?
Output in 2018–2022 was 346% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Flatiron Institute
- Tisch Cancer Institute
- Herbert Irving Comprehensive Cancer Center
- Microsoft Research New York City (United States)
- ICAP Global Health
- Fox Corporation (United States)
- Jane Street (United States)
- The Human Diagnosis Project
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.